spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  OrbiMed Advisors 

 HSMN NewsFeed - 16 Apr 2025
Xtant Medical Announces Secondary Private Sale of Existing Shares by OrbiMed and Preliminary First Quarter 2025 Revenue Growth of 18% to 19%
Devices Orthopaedic Wound Care Venture Capital
 HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Nov 2021
Alpheus Medical Closes $16M In Series A Financing For Novel Glioma Brain Cancer Treatment
Devices Oncology Venture Capital
 HSMN NewsFeed - 5 Feb 2021
Jubilant Therapeutics Appoints Dr. Robert Glassman to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Oct 2020
Q32 Bio Closes $60 Million Series B Financing, Advances to Clinical Stage Research in Therapeutics Designed to Restore Immune Homeostasis
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Oct 2020
Steven Yecies Joins Javelin Oncology as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Nov 2018
ORIC Pharmaceuticals Appoints Matt Panuwat as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Sep 2018
ORIC Pharmaceuticals Appoints Pratik Multani, MD, as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 May 2018
ORIC Has Appointed Jacob Chacko, MD as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Mar 2018
PMV Pharma Appoints Salim Yazji, M.D. as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jan 2018
Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Jan 2018
Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Dec 2017
ORIC Has Appointed Rich Heyman, PhD as Acting Chief Executive Officer and Leonard Reyno, MD as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 5 Dec 2017
PMV Pharma Appoints Winston Kung as COO & CFO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 May 2016
Graybug Vision Announces $44.5 Million Series B Financing
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 6 Jan 2016
NextCure, Inc., New Immuno-Oncology Firm, Announces $67 Million Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 6 Apr 2015
Natera, Inc., Non-Invasive Genetic Testing Leader, Secures $55 Million in Private Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jun 2014
Bayer HealthCare and Dimension Therapeutics to Develop Novel Gene Therapy for Hemophilia A
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2014
SAGE Therapeutics Closes $38M Oversubscribed Series C Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 13 Feb 2014
Principia Biopharma Expands Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2013
ViewRay(TM) Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System
Devices Oncology Venture Capital
 HSMN NewsFeed - 16 Oct 2013
Seragon Pharmaceuticals Raises $30M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Oct 2013
Loxo Oncology Raises $33 Million in Series A Financing to Fund Development of Small Molecule Oncology Drugs
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 9 Sep 2013
Keystone Heart's TriGuard(TM) Cerebral Protection Device Receives CE Marking
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 4 Sep 2013
Otonomy Completes $45.9 Million Series C Equity Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Sep 2013
Arsanis Inc Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jul 2013
Audentes Therapeutics Raises $30 Million in Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Apr 2013
Cleave Biosciences Adds New Investor and $10 Million to Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 Mar 2013
Acceleron Receives Two FDA Orphan Designations for ACE-536
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Oct 2012
Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 1 May 2012
Vessix Receives CE Mark For V2 Renal Denervation System(TM) For Treatment Of Hypertension
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 12 Apr 2012
Vessix Vascular Names Michael D. Gioffredi Chief Commercialization Officer
Devices Personnel
 HSMN NewsFeed - 2 Apr 2012
Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
Diganostics Venture Capital Personnel
 HSMN NewsFeed - 13 Mar 2012
ViewRay Closes Round of Series C Financing
Devices Radiology Oncology Venture Captial
 HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 23 Dec 2011
Acceleron Secures $30M Private Financing
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Aug 2011
Vessix Vascular Completes $23 Million Financing
Devices Interventional Venture Capital Personnel
 HSMN NewsFeed - 21 Jul 2011
Aegerion Pharmaceuticals Announces Appointment of Paul G. Thomas to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2011
OrbiMed Promotes Four to Public Equity Partnership
Venture Capital Personnel
 HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Sep 2010
Eddingpharm (Cayman) Inc. Announces Closing of Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2010
Aragon Pharmaceuticals Secures $22 Million in Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 5 Apr 2010
Selecta Closes $15 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Feb 2010
OrbiMed Launches $550 Million Venture Capital Fund
Biopharmaceuticals Devices Venture Capital
 HSMN NewsFeed - 4 Jan 2010
Pieris Appoints a New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2009
Acceleron Pharma Expands Management Team with Two New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Nov 2009
Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel Angiogenesis Inhibitor, in Patients with Advanced Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Oct 2009
Amarin Announces Changes to Its Board and Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2009
PharmAbcine Closes USD $6 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 May 2009
Aragon Pharmaceuticals Announces $8 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Apr 2009
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Devices Venture Capital
 HSMN NewsFeed - 6 Apr 2009
Cerapedics Closes $15 Million Series B Financing
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 12 Jan 2009
Singulex Closes $19 Million Financing Round
Diagnostics Venture Capital
 HSMN NewsFeed - 20 Nov 2008
Adimab, Inc. Announces Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Oct 2008
Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron(R) in Hepatitis C
Biopharmaceuticasl Venture Capital
 HSMN NewsFeed - 25 Sep 2008
MacroGenics Raises $25M in Series D-2 Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Sep 2008
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
Apoptos Inc. Raises $28 Million in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Mar 2008
Pieris Raises EUR 25 M (US$ 38 M) in Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jan 2008
ViewRay Incorporated Raises $25 Million in Series B Financing
Devices Venture Capital
 HSMN NewsFeed - 4 Jan 2008
Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2007
Pacira Pharmaceuticals Names David M. Stack CEO and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2007
SGX Pharmaceuticals Announces $25 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Nov 2007
Ambit Biosciences Raises Over $49 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Nov 2007
Aspect Medical Systems, Inc. Announces Agreement with Boston Scientific to Waive Lock-up and Call Option on Remaining Shares Held by Boston Scientific
Devices Surgery Neurology Monitoring
 HSMN NewsFeed - 30 Oct 2007
Acceleron Pharma Completes $31M Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2007
Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2007
Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2007
Enobia Pharma Raises $40.1 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Aug 2007
NeurAxon Announces $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur(R), a Novel Extended-Release Opioid Analgesic for Post Operative Pain
Biopharmaceuticals Distribution
 HSMN NewsFeed - 22 Jun 2007
SkyePharma Inc., Now a Private Pharmaceutical Company, Announces Name Change to Pacira Pharmaceuticals, Inc.
Biopharmaceuticals
 HSMN NewsFeed - 25 Apr 2007
Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2007
FDA Grants Full Approval for DepoCyt(R) for the Treatment of Lymphomatous Meningitis
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 29 Mar 2007
Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2007
Targanta Announces $70 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jan 2007
InteKrin Therapeutics Secures $23 M Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Jan 2007
Cerimon Pharmaceuticals Names Daniel Levitt, M.D., Ph.D. Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Cerexa to Be Acquired by Forest Laboratories for $480 Million Plus Potential $100 Million Milestone Payment
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Dec 2006
Cerimon Pharmaceuticals Names Ayse Kocak Vice President of Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2006
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2006
Innovative Spinal Technologies Names Frederic Moll, M.D., to Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 26 Sep 2006
Innovative Spinal Technologies Announces Launch of Paramount(TM) Pedicle Screw System for MIS Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 9 May 2006
YM Biosciences completes acquisition of Eximias
Biopharmaceuticals Oncology Mergers & Acquisitions
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
OrbiMed Advisors
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.